W. D. Travis, D. J. Giroux, K. Chansky, H. Asamura, E. Brambilla, J. Jett, C. Kennedy, R. Rami-Porta, V. W. Rusch and P. Goldstraw, “The IASLC Lung Cancer Staging Project: Proposals for the Inclusion of Broncho-Pulmonary Carcinoid Tumors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer,” Journal of Thoracic Oncology, Vol. 3, No. 11, 2008, pp. 1213-1223. doi:10.1097/JTO.0b013e31818b06e3

has been cited by the following article:

• TITLE: Comparison of Patient Survival after Resection for Pulmonary Carcinoid Tumors Compared to Other Neuroendocrine Tumors: A United States Population Study

  AUTHORS: Jay M. Bhatt, J. Nilas Young, David T. Cooke

  KEYWORDS: Lung Cancer; Carcinoid; Neuroendocrine Tumor; Thoracic Surgery

  JOURNAL NAME: Open Journal of Thoracic Surgery, Vol.2 No.4, December 6, 2012

  ABSTRACT: Background: We hypothesized: 1) resected pulmonary typical carcinoid (TC) will show a favorable clinical pattern compared to other bronchopulmonary neuroendocrine tumors (BPNETs); and 2) Atypical carcinoid (AC) and large-cell neuroendocrine carcinoma (LCNEC) patients will have similar outcomes. Methods: The Surveillance Epidemiology and End Result database was queried to compare demographics and tumor specific variables in patients undergoing resection for TC, AC, LCNEC and small cell lung cancer (SCLC) from 2001 to 2006. Results: Similar to LCNEC, AC patients had greater incidence of histologic positive lymph nodes compared to TC (P